Related Experiment Video

Updated: Jul 16, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Oral beta-lactams in the treatment of acute otitis media

Stan L Block1, Gary V Doern, Michael A Pfaller

  • 1Kentucky Pediatric/Adult Research, Bardstown, KY, USA.

Diagnostic Microbiology and Infectious Disease
|March 14, 2007
PubMed

Insights

Acute otitis media (AOM) management is challenged by changing bacteria. Current treatments for AOM should target beta-lactamase-positive bacteria like Haemophilus influenzae and Streptococcus pneumoniae.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Acute otitis media (AOM) is a common childhood infection with complex management challenges.
  • Changes in microbiology, including antimicrobial resistance and vaccine impact, complicate AOM treatment.
  • The heptavalent pneumococcal vaccine has reduced penicillin-nonsusceptible Streptococcus pneumoniae (PNSP) but increased beta-lactamase-positive nontypeable Haemophilus influenzae.

Purpose of the Study:

  • To evaluate the impact of recent microbiological shifts on AOM treatment strategies.
  • To assess the effectiveness of oral beta-lactam antibacterial agents against current AOM pathogens.
  • To inform empiric therapy recommendations for AOM.

Main Methods:

  • In vitro susceptibility testing of oral beta-lactam agents.
  • Surveillance programs monitoring bacterial pathogens causing AOM.
  • Application of pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.

Main Results:

  • Significant decrease in AOM caused by PNSP post-vaccine introduction.
  • Observed increase in AOM due to beta-lactamase-positive nontypeable Haemophilus influenzae.
  • In vitro data guides the selection of effective antibacterial agents.

Conclusions:

  • Empiric AOM therapy requires agents effective against both Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae.
  • Adjusted treatment strategies are necessary due to evolving pathogen prevalence.
  • Pharmacokinetic/pharmacodynamic data is crucial for projecting clinical efficacy.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...